286 related articles for article (PubMed ID: 35350597)
1. Rethinking growth factors: the case of BMP9 during vessel maturation.
Medina-Jover F; Riera-Mestre A; Viñals F
Vasc Biol; 2022 Feb; 4(1):R1-R14. PubMed ID: 35350597
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.
Tillet E; Bailly S
Front Genet; 2014; 5():456. PubMed ID: 25620979
[TBL] [Abstract][Full Text] [Related]
3. BMP9 regulates endoglin-dependent chemokine responses in endothelial cells.
Young K; Conley B; Romero D; Tweedie E; O'Neill C; Pinz I; Brogan L; Lindner V; Liaw L; Vary CP
Blood; 2012 Nov; 120(20):4263-73. PubMed ID: 23018639
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the ALK1 ligands, BMP9 and BMP10.
Li W; Salmon RM; Jiang H; Morrell NW
Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
[TBL] [Abstract][Full Text] [Related]
5. Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies.
Nolan-Stevaux O; Zhong W; Culp S; Shaffer K; Hoover J; Wickramasinghe D; Ruefli-Brasse A
PLoS One; 2012; 7(12):e50920. PubMed ID: 23300529
[TBL] [Abstract][Full Text] [Related]
6. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
[TBL] [Abstract][Full Text] [Related]
7. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
Upton PD; Davies RJ; Trembath RC; Morrell NW
J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
[TBL] [Abstract][Full Text] [Related]
9. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
[TBL] [Abstract][Full Text] [Related]
10. An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms.
Arthur HM; Roman BL
Front Med (Lausanne); 2022; 9():973964. PubMed ID: 36250069
[TBL] [Abstract][Full Text] [Related]
11. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II.
Kim JH; Peacock MR; George SC; Hughes CC
Angiogenesis; 2012 Sep; 15(3):497-509. PubMed ID: 22622516
[TBL] [Abstract][Full Text] [Related]
12. SGK1 is a signalling hub that controls protein synthesis and proliferation in endothelial cells.
Medina-Jover F; Gendrau-Sanclemente N; Viñals F
FEBS Lett; 2020 Oct; 594(19):3200-3215. PubMed ID: 32767771
[TBL] [Abstract][Full Text] [Related]
13. Atheroprone fluid shear stress-regulated ALK1-Endoglin-SMAD signaling originates from early endosomes.
Mendez PL; Obendorf L; Jatzlau J; Burdzinski W; Reichenbach M; Nageswaran V; Haghikia A; Stangl V; Hiepen C; Knaus P
BMC Biol; 2022 Sep; 20(1):210. PubMed ID: 36171573
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations.
Ricard N; Bidart M; Mallet C; Lesca G; Giraud S; Prudent R; Feige JJ; Bailly S
Blood; 2010 Sep; 116(9):1604-12. PubMed ID: 20501893
[TBL] [Abstract][Full Text] [Related]
15. BMP9 Induces Cord Blood-Derived Endothelial Progenitor Cell Differentiation and Ischemic Neovascularization via ALK1.
Kim J; Kim M; Jeong Y; Lee WB; Park H; Kwon JY; Kim YM; Hwang D; Kwon YG
Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2020-31. PubMed ID: 26229139
[TBL] [Abstract][Full Text] [Related]
16. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.
David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S
Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.
Salmon RM; Guo J; Wood JH; Tong Z; Beech JS; Lawera A; Yu M; Grainger DJ; Reckless J; Morrell NW; Li W
Nat Commun; 2020 Apr; 11(1):1621. PubMed ID: 32238803
[TBL] [Abstract][Full Text] [Related]
20. Arterial endoglin does not protect against arteriovenous malformations.
Singh E; Redgrave RE; Phillips HM; Arthur HM
Angiogenesis; 2020 Nov; 23(4):559-566. PubMed ID: 32506200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
